Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy-Reference-Cited by-同舟云学术

Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy

Published:2012-02-04 Issue:3 Volume:95 Page:291-298
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Takasaki Hirotaka,Tanaka Masatsugu,Tachibana Takayoshi,Numata Ayumi,Fujimaki Katsumichi,Sakai Rika,Fujisawa Shin,Tomita Naoto,Fujita Hiroyuki,Maruta Atsuo,Ishigatsubo Yoshiaki,Kanamori Heiwa

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-012-1009-x.pdf

Reference27 articles.

1. Yanada M, Emi N, Naoe T, Sakamaki H, Iseki T, Hirabayashi N, et al. Allogeneic myeloablative transplantation for patients aged 50 years and over. Bone Marrow Transplant. 2004;34:29–35.

2. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756–63.

3. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390–400.

4. de Lima M, Anagnostopoulos A, Munsell M, Shahjahan M, Ueno N, Ippoliti C, et al. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. Blood. 2004;104:865–72.

5. Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, Kolb H-J, et al. Comparative outcome of reduced Intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia. 2005;19:2304–12.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the pre-transplantation serum ferritin level and outcomes of hematopoietic stem cell transplantation: A systematic review and meta-analysis;Heliyon;2024-09

2. Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis;Bone Marrow Transplantation;2023-02-27

3. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns;Drugs & Aging;2018-10-09

4. Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities;Biology of Blood and Marrow Transplantation;2018-07

5. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias.;International Journal of Hematology and Oncology;2016-03-01